ArticleBMC infectious diseases2026
Temporal cytokine profiling of acute dengue, Zika, Chikungunya, and Mayaro virus infections in Northern Peru.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Host-derived immune signatures as biomarkers to differentiate arboviral acute febrile illness from other causes of acute fever.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundArboviruses such as Dengue virus (DENV), Chikungunya virus (CHIKV), Zika virus (ZIKV), and Mayaro virus (MAYV) are major causes of acute febrile illness (AFI) in Peru. However, their overlapping clinical symptoms complicate differential diagnosis. Identifying immunological markers like cytokine profiles could facilitate differential diagnosis and improve understanding of their immunopathogenesis. This study aimed to describe the cytokine responses (IL-2, IL-6, IL-10, TNF-α, IFN-γ) associated with each infection.
methodsA cross-sectional study was conducted from June 2020 to April 2022 in Cajamarca, Peru, including 20 patients each with DENV, CHIKV, ZIKV, or MAYV infection, and 20 healthy controls. Infections were confirmed by RT-PCR and virus-specific IgM ELISAs. Serum cytokine levels (IL-2, IL-6, IL-10, TNF-α, IFN-γ) were measured by ELISA. Cytokine profiles were compared across the four infections and controls, and cytokine kinetics were analyzed by stratifying patients by days post-symptom onset.
resultsAll four infections presented with overlapping acute symptoms (e.g., fever, headache, myalgia, arthralgia). Despite these clinical similarities, each infection presented a different cytokine profile. IL-2 levels were comparable among the arbovirus groups (though higher in DENV and patients with ZIKV infection than in controls). IL-6 was elevated predominantly in CHIKV and ZIKV; IL-10 was highest in DENV; and TNF-α and IFN-γ were significantly elevated in DENV and ZIKV (with DENV levels exceeding those in MAYV). Analysis of cytokine dynamics showed that levels of all five cytokines generally peaked early (days 1–4 post-symptom onset) and declined thereafter, with the timing and magnitude of peak responses varying by virus.
conclusionEach arboviral infection analyzed presented a distinct cytokine profile, with elevated IL-6 levels in CHIKV and ZIKV. IL-2, IL-10, TNF-α, and IFN-γ levels were elevated among the flaviviruses studied, with a delayed increase in IL-2 observed in ZIKV patients. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.